Suppr超能文献

肝细胞癌(HCC)经药物洗脱微球(DEB)化疗栓塞后的长期复发分析。

Long term recurrence analysis post drug eluting bead (deb) chemoembolization for hepatocellular carcinoma (hcc).

作者信息

Malagari Katerina, Pomoni Mary, Sotirchos Vlasis S, Moschouris Hippokratis, Bouma Evanthia, Charokopakis Angelos, Kelekis Alexios D, Koundouras Dimitrios, Filippiadis Dimitris, Chatziioannou Achilles, Karagiannis Evangelos, Thanos Loukas, Alexopoulou Efthymia, Pomoni Anastasia, Dourakis Spyridon, Kelekis Dimitrios A

出版信息

Hepatogastroenterology. 2013 Sep;60(126):1413-9. doi: 10.5754/hge13187.

Abstract

UNLABELLED

BACKROUND-AIMS: To determine long term outcomes, regarding recurrence and survival, in patients with HCC that achieved complete response after initial treatment with drug eluting beads (DEB) using DC Bead loaded with doxorubicin (DEB-DOX).

METHODOLOGY

Forty-five patients with HCC, not suitable for curative treatments that exhibited complete response (EASL criteria) to initial DEB-DOX treatment were retrospectively analyzed after a median follow up period of 63 months. Child-Pugh class was A/B (62.2/37.8%) and mean lesion diameter 5.36 ± 1.1 cm. Lesion morphology was one dominant ≤5cm (53.3%), one dominant >5cm (31.1%) and multifocal (15.6%).

RESULTS

At 5 years, overall survival was 62.2% and recurrence-free survival 8.9%. All deaths that occurred were related to tumor progression (31.1%) or complications of underlying liver disease (28.9%). Median time of initial recurrence from baseline treatment was 18 months (range 8-52). When recurrence occurred, a mean time interval between additional DEB-DOX procedures less than 9 months was correlated to a poorer prognosis (p=0.025). Multivariate analysis identified Child-Pugh class at baseline (p=0.048), combined therapy of recurrences with local ablation (p=0.03) and number of DEB-DOX procedures (p=0.037) as significant prognostic factors of 5-year survival. Lesion morphology displayed significance for recurrence-free survival (p=0.014). Child-Pugh class at baseline, additional local ablation, pattern of initial recurrence and initial sum of recurrent tumor diameters all displayed statistical significance for post-recurrence survival (median 40 months), with the first two variables maintaining statistical significance in multivariate analysis (p=0.015 and p=0.014 respectively).

CONCLUSION

Initial complete response to DEB-DOX ensures a favorable prognosis. However, management of recurrent tumors, which occur frequently mostly as new lesions, and preservation of underlying liver function appear to play a key role in prolonging survival.

摘要

未标注

背景与目的:确定使用载有多柔比星的DC微球(DEB-DOX)进行初始治疗后达到完全缓解的肝癌患者的复发和生存等长期预后情况。

方法

对45例不适合进行根治性治疗且对初始DEB-DOX治疗表现出完全缓解(符合欧洲肝脏研究学会标准)的肝癌患者进行回顾性分析,中位随访期为63个月。Child-Pugh分级为A/B级(分别占62.2%/37.8%),平均病灶直径为5.36±1.1厘米。病灶形态为单个≤5厘米占主导(53.3%)、单个>5厘米占主导(31.1%)和多灶性(15.6%)。

结果

5年时,总生存率为62.2%,无复发生存率为8.9%。所有死亡均与肿瘤进展(31.1%)或潜在肝脏疾病并发症(28.9%)有关。从基线治疗开始的初始复发中位时间为18个月(范围8 - 52个月)。当复发发生时,额外DEB-DOX治疗程序之间的平均时间间隔小于9个月与较差的预后相关(p = 0.025)。多变量分析确定基线时的Child-Pugh分级(p = 0.048)、复发时联合局部消融治疗(p = 0.03)以及DEB-DOX治疗程序的次数(p = 0.037)为5年生存率的显著预后因素。病灶形态对无复发生存率有显著意义(p = 0.014)。基线时的Child-Pugh分级、额外的局部消融、初始复发模式以及复发肿瘤直径总和对复发后生存(中位40个月)均具有统计学意义,前两个变量在多变量分析中仍保持统计学意义(分别为p = 0.015和p = 0.014)。

结论

对DEB-DOX的初始完全缓解确保了良好的预后。然而,复发性肿瘤的管理(其大多频繁以新病灶形式出现)以及潜在肝功能的保护似乎在延长生存期方面起着关键作用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验